Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "new drug development"
Home
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are currently underway here.
07/31/2026, 09:57 ET
Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology
Daegu has been selected to host the 2034 World Congress of Basic & Clinical Pharmacology (WCP 2034), marking the first time South Korea will hold the...
07/26/2026, 08:05 ET
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals
The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...
07/06/2026, 03:43 ET
Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development
The new drug development platform Pharmulator™ has officially made its debut on the international stage—not at a...
02/12/2026, 01:05 ET
Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won
Boryung is setting compensation at its soon-to-be spun-off prescription drug sales division above parent-company...
09/25/2026, 10:22 ET
‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital
Global life sciences investment firm Novo Holdings is bringing its proven European biotech company-building playbook to...
09/21/2026, 22:03 ET
“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families
“Until just before my daughter turned 2, she frequently suffered not only febrile seizures but also afebrile seizures.
09/21/2026, 21:59 ET
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group
Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
09/21/2026, 02:06 ET
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
09/13/2026, 10:34 ET
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion
Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.
09/13/2026, 10:33 ET
1
2
3
Next